In the course of the international development of biolog-id and in preparation for the IPO, the company’s board of directors has appointed Troy Hilsenroth as CEO of biolog-id worldwide. This appointment took effect on November 1 , 2021.
With 29 years of experience, Troy Hilsenroth has in-depth knowledge of the healthcare sector. Before joining biologid as CEO of biolog-id LLC North-America in 2019, Troy Hilsenroth was Vice President and General Manager of the Medication Adherence division at Omnicell, where he has built up and expanded a global division over the past 10 years. Before that, he held management positions in the pharmaceutical sector in renowned healthcare facilities.
” After 2 years as CEO for the North American region, I am very proud and look forward to taking over the management of all activities at biolog-id,” said Troy Hilsenroth. “ I have always been convinced that biolog-id has enormous potential to contribute to the digital transformation of the healthcare industry and I am very honored to take on this new position to support the company in preparing for its IPO. I look forward to writing the next chapter of this success story together with the board of directors and all employees. ”
Also Read: Should Bank Rethinks about their Data Monetization Effort
” As the company’s founder and CEO, I am delighted that Troy Hilsenroth is taking on this new role,” explains Jean-Claude Mongrenier. “ Troy has demonstrated a great vision for how our business will grow over the past several years with the company. Thanks to him, our solutions have been successfully used in major US blood banks. We all agree that with Troy Hilsenroth we have an outstanding leader and the board is confident that Troy will create the necessary conditions for entry into the stock market. ”
Founded in 2005, biolog-id has patented technology that enables healthcare professionals to track and manage sensitive health products all the way from donor to patient. With more than 100 employees, the company currently operates in 14 countries in North America, Europe, the Middle East, India and the Asia-Pacific region.